from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3861/-

LFCtreatmentdescriptionclass of inhibitor

-0.217

Amikacinug/mL Amikacintranslation

-0.035

Cap5-10ug/mL Capreomycintranslation

-1.036

Rox10-50 ug/mL Roxithromycintranslation

-0.178

SM2-5 ug/mL Streptomycintranslation

0.631

Tet5-10 ug/mL Tetracyclinetranslation

-1.491

Rif0.2-5ug/mL Rifampicintranscription

0.099

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.524

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.151

CPZ10-50 ug/mL Chlorpromazinerespiration

0.980

Clofazimine10-13 ug/mL Clofaziminerespiration

1.252

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.837

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.067

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.855

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.678

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.745

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.064

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.068

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.709

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.845

Nigericin50 uM Nigericinrespiration

0.145

TRC10-150 ug/mL Triclosanrespiration

0.119

TRZ10-25 ug/mL Thioridazinerespiration

0.568

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.093

menadione6-10 ug/mL Menadionerespiration

0.108

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.020

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.079

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.192

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.494

NRP_1Non-replicating persistence stage 1dosRassociated

-0.582

Amp0.2mg/mL AmpicillincellWall

0.046

Cephalexin20-100 ug/mL CephalexincellWall

-0.101

Cerulenin0.32-5 ug/mL CerulenincellWall

0.103

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.070

EMB10-20 ug/mL EthambutolcellWall

-0.399

Eta12-40 ug/mL EthionamidecellWall

-0.517

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.485

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.404

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.229

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.123

BZA0.12 mg/mL BenzamidearomaticAmides

-0.355

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.151

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.130

H2O24 mM hydrogen peroxideDNAdamaging

-0.484

Levo10 ug/mL LevofloxacinDNAdamaging

-0.139

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.413

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.194

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.393

UVUV-irradiationDNAdamaging

-1.320

ARP41-4 ug/mL Antitubercular compound ARP4?

0.624

Antimycin12.5-50 ug/mL Antimycin A?

-1.154

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.565

PA_110-50 ug/mL Antitubercular compound PA-1?

0.896

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.419

PA8240.2-2 ug/mL PA-824?

1.189

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.540

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.052

Verapamil50 uM Verapamil?

-1.389

mercaptoethanol2 mM 2-Mercaptoethanol?

0.113

methoxatin10-20 ug/mL Methoxatin?